- ►diabetes.com.au [PDF] KGMM Alberti, P Zimmet, J Shaw - The Lancet, 2005 - Elsevier The ultimate importance of metabolic syndrome is that it helps identify
individuals at high risk of both type 2 diabetes and cardiovascular disease
(CVD). Several expert groups have therefore attempted to produce diagnostic ... Cited by 2152 - Related articles - BL Direct - All 11 versions
- ►ufl.edu [PDF] L Sjostrom, AK Lindroos, M Peltonen, J … - The New England journal of medicine, 2004 - nejm.highwire.org From the Departments of Body Composi- tion and Metabolism (LS, A.-KL, BC, KN,
MS) and Anesthesiology (BL, CDS), Sahlgrenska University Hospital, Göteborg,
Nordic University of Public Health (HW), Göteborg; the Medical De- ... Cited by 758 - Related articles - All 12 versions
- ►annals.org MA Maggard, LR Shugarman, M Suttorp, M … - Annals of internal medicine, 2005 - Am Coll Physicians From the Southern California Evidence-Based Practice Center (which includes RAND
Health Division, Santa Monica, California, and the Greater Los Angeles VA
Healthcare System, Los Angeles) and the University of California, Los ... Cited by 452 - Related articles - BL Direct - All 10 versions
- ►biosino.org [PDF] JP Després, I Lemieux - NATURE-LONDON-, 2006 - Springer Despite the fact that the obesity epidemic has received intense media cover-
age, many physicians still fail to recognize that the rapidly growing prevalence
of type 2 diabetes in their practice is the result of our “toxic” ... Cited by 424 - Related articles - BL Direct - All 9 versions
Z Li, M Maglione, W Tu, W Mojica, D … - Annals of internal medicine, 2005 - Am Coll Physicians Background: In response to the increase in obesity, pharmacologic treatments for
weight loss have become more numerous and more commonly used. ... Purpose: To
assess the efficacy and safety of weight loss medications approved by the ... Cited by 321 - Related articles - BL Direct - All 8 versions
- ►ahajournals.org S Klein, LE Burke, GA Bray, S Blair, DB … - Circulation, 2004 - Am Heart Assoc Obesity adversely affects cardiac function, increases the risk factors for
coronary heart disease, and is an independent risk factor for cardiovascular
disease. The risk of developing coronary heart disease is directly related ... Cited by 273 - Related articles - BL Direct - All 8 versions
DE Moller, KD Kaufman, 2004 - Annual Reviews The metabolic syndrome is a cluster of interrelated common clinical disorders,
including obesity, insulin resistance, glucose intolerance, hypertension, and
dyslipidemia (hypertriglyceridemia and low HDL cholesterol levels). ... Cited by 227 - Related articles - All 6 versions
RS Padwal, SR Majumdar - The Lancet, 2007 - Elsevier Antiobesity treatment is recommended for selected patients in whom lifestyle
modification is unsuccessful. Two antiobesity drugs are currently licensed for
long-term use. Orlistat, a gastrointestinal lipase inhibitor, reduces ... Cited by 207 - Related articles - All 11 versions
- ►diabetesjournals.org S Klein, NF Sheard, X Pi-Sunyer, A Daly, J … - Diabetes Care, 2004 - Am Diabetes Assoc The prevalence of diabetes in the US continues to rise by epidemic proportions.
This increase parallels the rising rates of obesity and overweight observed over
the past decade (1,2). Indeed, as BMI increases, the risk of developing ... Cited by 190 - Related articles - BL Direct - All 23 versions
